Robert F. Apple
Director/Board Member chez KAZIA THERAPEUTICS LIMITED
Postes actifs de Robert F. Apple
Sociétés | Poste | Début | Fin |
---|---|---|---|
KAZIA THERAPEUTICS LIMITED | Director/Board Member | 18/01/2024 | - |
Historique de carrière de Robert F. Apple
Anciens postes connus de Robert F. Apple
Sociétés | Poste | Début | Fin |
---|---|---|---|
ANTARES PHARMA, INC. | Comptroller/Controller/Auditor | 08/06/2010 | 05/07/2012 |
Director/Board Member | 04/03/2016 | 24/05/2022 | |
Chief Executive Officer | 24/01/2016 | 24/05/2022 | |
Chief Operating Officer | 15/09/2014 | 24/01/2016 | |
Director of Finance/CFO | 01/02/2006 | 18/11/2014 | |
President | 24/01/2016 | 24/05/2022 | |
Corporate Secretary | 01/02/2006 | 15/09/2014 | |
PAXMEDICA, INC. | Director/Board Member | 01/06/2020 | 01/04/2022 |
Independent Dir/Board Member | 01/06/2020 | 01/04/2022 | |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | Chief Operating Officer | 01/01/2003 | 01/01/2005 |
Director of Finance/CFO | 01/01/1997 | 01/01/2002 | |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Comptroller/Controller/Auditor | 01/01/1995 | 01/10/1997 |
Liberty Technologies, Inc. /Pennsylvania/ | Comptroller/Controller/Auditor | 01/05/1994 | 01/07/1995 |
Kerathin LLC
Kerathin LLC Medical SpecialtiesHealth Technology Kerathin LLC manufactured medical devices for the treatment of diseased and dystrophic nails. It offered podiaPRO-H1, a device that provides improvement in nail debridement. The company was founded by Tom Fitzsimons and Beth Fitzsimons in May 2010 and was headquartered in Chester, PA. | Director/Board Member | - | - |
Formation de Robert F. Apple
Temple University (Pennsylvania) | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Australie | 2 |
Opérationnelle
Director/Board Member | 4 |
Comptroller/Controller/Auditor | 3 |
Chief Operating Officer | 2 |
Sectorielle
Health Technology | 7 |
Electronic Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
KAZIA THERAPEUTICS LIMITED | Health Technology |
PAXMEDICA, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
Liberty Technologies, Inc. /Pennsylvania/ | Electronic Technology |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | Health Technology |
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Kerathin LLC
Kerathin LLC Medical SpecialtiesHealth Technology Kerathin LLC manufactured medical devices for the treatment of diseased and dystrophic nails. It offered podiaPRO-H1, a device that provides improvement in nail debridement. The company was founded by Tom Fitzsimons and Beth Fitzsimons in May 2010 and was headquartered in Chester, PA. | Health Technology |
- Bourse
- Insiders
- Robert F. Apple
- Expérience